Stjepana R. Kovac

Queen Square
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 119 publications

Immune context and treatment timing associated with seizure freedom after rituximab in autoimmune limbic encephalitis.

Immune context and treatment timing associated with seizure freedom after rituximab in autoimmune limbic encephalitis.

Journal: iScience

Published: January 28, 2026

T1w/T2w Ratio Identifies the Basolateral Amygdala as a Preferential Target in Autoimmune Limbic Encephalitis.

T1w/T2w Ratio Identifies the Basolateral Amygdala as a Preferential Target in Autoimmune Limbic Encephalitis.

Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging

Published: November 26, 2025

Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 Patients.

Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis: Long-Term Outcome in 236 Patients.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: September 15, 2025

Clinical reliability and concordance of drug-drug interaction tools as clinical decision support systems in patients with epilepsy.

Clinical reliability and concordance of drug-drug interaction tools as clinical decision support systems in patients with epilepsy.

Journal: Seizure

Published: August 25, 2025

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.

Journal: JAMA neurology

Published: August 04, 2025

Clinical Reasoning: Episodes of Uncontrollable Crying in a 52-Year-Old Man With a Sphenopetroclival Tumor.

Clinical Reasoning: Episodes of Uncontrollable Crying in a 52-Year-Old Man With a Sphenopetroclival Tumor.

Journal: Neurology

Published: June 26, 2025

Cytoskeletal disruption-induced calcium dysregulation drives cell death in anti-IgLON5 disease.

Cytoskeletal disruption-induced calcium dysregulation drives cell death in anti-IgLON5 disease.

Journal: Redox biology

Published: June 13, 2025

Occurrence and treatment of depression symptoms and anxiety in patients with epilepsy: Findings from a German multicentre cross-sectional study.

Occurrence and treatment of depression symptoms and anxiety in patients with epilepsy: Findings from a German multicentre cross-sectional study.

Journal: Epilepsy & behavior : E&B

Published: February 01, 2025

Brain atrophy patterns in anti-IgLON5 disease.

Brain atrophy patterns in anti-IgLON5 disease.

Journal: Brain : a journal of neurology

Published: November 11, 2024

Characterization of immune cell profiles in the blood of children and adults with tuberous sclerosis complex disease.

Characterization of immune cell profiles in the blood of children and adults with tuberous sclerosis complex disease.

Journal: Journal of the neurological sciences

Published: November 02, 2024

Retraction Note to: Apoptosis Following Cortical Spreading Depression in Juvenile Rats.

Retraction Note to: Apoptosis Following Cortical Spreading Depression in Juvenile Rats.

Journal: Molecular neurobiology

Published: October 19, 2024

Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies.

Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies.

Journal: Journal of neuroinflammation

Published: September 15, 2024

Showing 1-12 of 119

Last Updated: 09/26/2026